Carl Zeiss Meditec AG
CZMWY · OTC
Financial statements
Annual and quarterly income, balance-sheet, cash-flow and key-statistics data.
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2022 FY | 1.90B | 1.13B | 372.02M | 293.91M | 3.29 |
| 2023 FY | 2.09B | 1.21B | 327.14M | 290.40M | 3.25 |
| 2024 FY | 2.07B | 1.09B | 121.35M | 178.73M | 2.01 |
| 2025 FY | 2.23B | 1.18B | 223.32M | 141.21M | 1.52 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2022 FY | 2.82B | 792.73M | 7.73M | 127.90M | 2.02B |
| 2023 FY | 3.03B | 860.02M | 10.60M | 155.70M | 2.16B |
| 2024 FY | 3.39B | 1.34B | 20.29M | 153.83M | 2.04B |
| 2025 FY | 4.06B | 1.56B | 27.27M | 132.46M | 2.49B |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2022 FY | 188.20M | -81.97M | 106.23M | -80.50M | 290.00K |
| 2023 FY | 250.86M | -113.86M | 137.00M | -98.39M | 2.87M |
| 2024 FY | 247.32M | -152.20M | 95.12M | -98.20M | 9.68M |
| 2025 FY | 231.68M | -43.49M | 188.19M | -57.98M | 9.40M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2022 FY | 9.46B | 9.58B | — | — | — |
| 2023 FY | 7.41B | 7.56B | — | — | — |
| 2024 FY | 6.31B | 6.44B | — | — | — |
| 2025 FY | 3.72B | 3.82B | — | — | — |
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 Q3 | 549.63M | 289.70M | 53.06M | 28.38M | 0.33 |
| 2025 Q4 | 627.55M | 610.89M | 71.08M | 51.81M | 0.90 |
| 2026 Q1 | 467.00M | 227.20M | -300.00K | -4.90M | -0.06 |
| 2026 Q2 | 1.00B | 497.29M | 37.52M | 14.87M | 0.17 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2025 Q3 | — | -2.09B | — | — | 2.09B |
| 2025 Q4 | 4.06B | 1.56B | 27.27M | 132.46M | 2.49B |
| 2026 Q1 | — | -2.13B | — | — | 2.13B |
| 2026 Q2 | 3.34B | 1.23B | 23.92M | 618.20M | 2.10B |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2025 Q3 | 57.19M | — | 97.79M | — | — |
| 2025 Q4 | 198.61M | -19.00M | 179.51M | -4.00M | 2.87M |
| 2026 Q1 | — | — | — | — | — |
| 2026 Q2 | 100.28M | -10.19M | 90.09M | -48.81M | -3.91M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2025 Q3 | 4.99B | 4.99B | — | — | — |
| 2025 Q4 | 3.72B | 3.82B | — | — | — |
| 2026 Q1 | 3.26B | 3.26B | — | — | — |
| 2026 Q2 | 2.14B | 2.74B | — | — | — |